The viral antigens market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The growth of the market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics platforms for viral antigen detection. Further, the emerging markets offer lucrative opportunities to the global viral antigens market players. However, the high cost of vaccine development hinders the market growth.
A virus can infect all types of life forms, from plants and animals to archaea and bacteria.A viralus antigen is a poison or toxic substance administered by by a virus these virulent entities, which that induces an immune reaction in its host.
A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response.For instance, Aa viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA.
Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum. Based on component, the global viral antigens market is sub-segmented into Iinfluenza Vviral antigens, Ccoronavirus antigens, Zika Vvirus Aantigens, Ebola Aantigens, Dengue Aantigens, Herpes Simplex Vvirus (HSV) Aantigens, Rrotavirus antigens, Hepatitis A-E antigens, Mmeasles antigens, mumps/parotitis antigens, and others.The Coronavirus antigens segment held the largest share of the market in 2019, and it is expected to register a the higher highest CAGR during the forecast period.
Based on technique, the global viral antigens market is segmented into ELISA, immunoassay, hemagglutination, Rradioimmunoassay (RIA), immunoperoxidase staining, immunofluorescence, and others.The clinics segment held the largest share of the market in 2019, and is expected to register the highest CAGR during the forecast period.
Based on end user, the global viral antigens market is segmented into hospitals, clinics, laboratories, diagnostic centers, blood banks, and research institutes. The diagnostic centers segment held the largest share of the market in 2019, and the market for laboratories is expected to register grow at the highest CAGR during the forecast period.
The US Food and Drug Administration (FDA), Centers for Disease Control and Prevention’s (CDC), and National Health Agency (ANVISA) are among a few secondary sources referred to for preparing this report.
Our reports have been used by over 10K customers, including:
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
206 pages •
By The Business Research Company
• Dec 2020
Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global pegfilgrastim biosimilars market. Description: Where is the largest and fastest growing...
The fill finish manufacturing market was valued at US$ 6,129.03 million in 2019 and is projected to reach US$ 12,547.23 million by 2027; it is expected to grow at a CAGR of 9.6% from 2020 to 2027. The growth of the fill finish manufacturing market is mainly attributed to factors such as rising adoption of prefilled syringes for parenteral...
The global biologics CDMO market (henceforth, referred to as the market studied) was valued at USD 9.93 billion in 2020, and it is expected to reach USD 18.90 billion by 2026, registering a CAGR of 11.2% during 2021-2026 (henceforth, referred to as the forecast period).? - The global pharmaceutical industry is growing at an exponential...
The whole slide imaging market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. Technological advancements in whole slide imaging and increase in adoption of digital pathology. However, the high cost involved in the installation and...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
The injectable drugs market is expected to register a CAGR of nearly 11.1% during the forecast period. With an upsurge in the number of chronic diseases like diabetes and cancer, the need for drug delivery systems has risen substantially in the market. From the past one era of healthcare, biologics are increasingly becoming the driving...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
The biosafety cabinets market was valued at US$ 166.67 million in 2019 and is projected to reach US$ 312.90 million by 2027; it is expected to grow at a CAGR of 8.2%during 2020-2027. The growth of the biosafety cabinets market is mainly attributed to factors such as the increasing prevalence of infectious diseases and rising technological...
Biopharmaceutical
Infectious Disease
World
APAC
Europe
Health Expenditure
Infectious Disease Incidence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.